QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-in-line-on-teladoc-health-lowers-price-target-to-8

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price targe...

 update-teladoc-health-q3-adj-eps-020-beats-027-estimate-sales-626439m-beat-625913m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.27) ...

 teladoc-health-sees-q4-gaap-eps-025-010-vs-017-est-sees-sales-622000m-652000m-vs-634855m-est

Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.25)-$(0.10) vs $(0.17) analyst estimate. sees sales of $622.000 mi...

 teladoc-health-narrows-fy2025-gaap-eps-guidance-from-135-100-to-125-110-vs-112-est-narrows-fy2025-sales-guidance-from-2501b-2548b-to-2510b-2539b-vs-2522b-est

Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) analyst estimate...

 teladoc-health-q3-eps-028-misses-026-estimate-sales-626439m-beat-625913m-estimate

Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26...

 retail-investors-top-stocks-with-earnings-this-week-sofi-apple-meta-and-more

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites. 

 teladoc-health-reaffirms-its-2025-fy-consolidated-revenue-of-2501b-2548b-and-adjusted-ebita-outlook-issued-on-july-29-2025

In conjunction with this leadership announcement, Teladoc Health reaffirmed its 2025 full-year consolidated revenue and adjuste...

 teladoc-health-announces-cfo-mala-murthy-will-step-down-on-november-21-2025-and-search-has-begun-for-her-successor

Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her ...

 citigroup-maintains-neutral-on-teladoc-health-raises-price-target-to-105

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $9....

 why-teladoc-health-tdoc-stock-is-trading-higher-wednesday

Shares of Teladoc Health Inc (NYSE: TDOC) are trading higher and trending Wednesday afternoon. Here's what investors need t...

 evercore-isi-group-maintains-in-line-on-teladoc-health-raises-price-target-to-9

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and raises the price targe...

 teladoc-tdoc-shares-climb-on-bullish-commentary-from-citron-research

Shares of Teladoc Health are surging Friday morning after Citron Research posted a bullish note on the telehealth provider.

 citron-research-posts-on-x-tdoc--we-were-not-wrong-just-early-reason-for-recent-is-last-time-livongo-maus-were-this-strong-the-stock-was-15-today-its-85-even-as-bofa-just-reported-livongo-usage-55-yy-the-biggest-jump-since-jan-25--livongo-is-the-saas-backbone-of-teladoc-recurring

https://x.com/citronresearch/status/1974106818939920519?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 teladoc-health-announces-it-has-acquired-telecare-financial-terms-not-disclosed

Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Austra...

 teladoc-health-reports-smaller-than-expected-q2-loss-revenue-tops-estimates

Teladoc announces second-quarter revenue of $631.9 million, beating analyst estimates of $623.1 million.

 teladoc-health-sees-q3-gaap-eps-035-020-vs-018-est-sees-sales-614000m-636000m-vs-628009m-est

Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.35)-$(0.20) vs $(0.18) analyst estimate. sees sales of $614.000 mi...

 teladoc-health-narrows-fy2025-gaap-eps-guidance-from-140-090-to-135-100-vs-108-est-narrows-fy2025-sales-guidance-from-2468b-2576b-to-2501b-2548b-vs-2517b-est

Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.40)-$(0.90) to $(1.35)-$(1.00) vs $(1.08) analyst estimate...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION